Abstract. A panel of 17 monoclonal antibodies (MAbs) against Schistosoma soluble egg antigens (SEAs) was produced from BALB/c mice immunized with antigens secreted/excreted by Schistosoma mansoni eggs. In this study, we demonstrate that 16 MAbs were reactive with S. haematobium SEA in addition to S. mansoni SEA. The MAbs were tested as potential immunodiagnostic reagents in a homologous sandwich ELISA format to detect circulating soluble egg antigens (CSEAs) in serum and urine samples of S. mansoni-or S. haematobium-infected individuals. When samples of S. mansoni-infected individuals were tested, none of these MAbs performed as good as the previously described S. mansoni-specific 114-5B1-A and 114-4D12-A MAbs. However, 11 MAbs (of the IgM isotype) detected CSEA in urine samples of S. haematobium-infected individuals. Three MAbs, 290-2E6-A, 291-3D5-A, and 291-5D5-A, were selected for a pilot study with 47 urine samples of S. haematobium-infected individuals from Kenya. The CSEA levels detected with each of these ELISAs showed a significant correlation with urinary egg counts (Spearman rho Ͼ 0.37, P Ͻ 0.01) and with each other (Spearman rho Ͼ 0.74, P Ͻ 0.001). Based on the 92% specificity and 90% sensitivity of the assay, the ELISA using MAb 290-2E6-A was found to be the most promising assay for immunodiagnosis of S. haematobium infections.
For the quantitative diagnosis of schistosomiasis, research has mainly been focused on the development of assays for detection of circulating schistosome adult worm antigens in serum and urine samples of patients. The antigens most studied are the circulating anodic antigen (CAA) and the circulating cathodic antigen (CCA). Both antigens are genus-specific and have been detected in serum and urine from patients infected with Schistosoma mansoni, 1 S. haematobium, 2 S. intercalatum, 3 and S. japonicum. 4 However, determination of CCA or CAA levels is an assessment of worm burden rather than of egg burden.
Many eggs never reach the external environment, but are trapped in host tissue. The induction of granulomata around the eggs may, depending on the species, lead to fibrosis of the liver or urinary bladder and is the main cause of pathology in schistosomiasis. An egg antigen-specific assay might give more complete information on egg burden than the (generally applied method of) egg counts in feces and urine. Apart from providing valuable information on tissue egg load, such an assay would be very useful to study the anti-fecundity effect of vaccine candidates.
Although there are numerous studies describing the production and characterization of monoclonal antibodies (MAbs) reactive with schistosomal egg antigens, the number of reports dealing with their application in immunodiagnosis is limited. Moreover, most assays described probably detect antigen that is derived from both the egg and the worm. Ripert and others 5 described a passive hemagglutination test that detected a polysaccharide antigen present in all stages of the parasite, but abundant in eggs. An assay detecting a 70-kD protein found in both eggs and adult worms of S. japonicum has been reported by Fu and Carter. 6 A combination of CAA detection with assays for two circulating S. japonicum egg antigens was recently reported by Lu and others 7 to increase diagnostic efficiency. An S. mansoni-specific antigen-capture ELISA that detects a circulating antigen that is more concentrated in eggs than in adult worms was reported by Hassan and others. 8 Recently, a new assay that sensitively detects S. mansoni antigens in serum and urine has been demonstrated. 9 This assay, however, appeared to be considerably less sensitive for diagnosis of S. haematobium. Recently, Bosompem and others 10 described a sensitive fieldapplicable dipstick assay for specific diagnosis of urinary schistosomiasis. The assay uses an S. haematobium-specific MAb that detects a 29-kD peptide.
The characterization of two MAbs specific for S. mansoni circulating soluble egg antigens (CSEAs) has been reported previously by our laboratory. 11, 12 The assays developed using these MAbs could detect CSEA in serum and urine samples of S. mansoni-infected patients and showed no reactivity in noninfected individuals. However, for very low infection intensities, these assays lacked sensitivity compared with (repeated) egg counts in feces and CCA and CAA measurements (Nibbeling HAM, unpublished data). We have therefore tried to select new MAbs showing a higher sensitivity in immunodiagnosis of S. mansoni infections. Mice were immunized with S. mansoni hatching fluid (HF) containing miracidial excretory or surface coat products. Although none of the obtained MAbs showed improvement in immunodiagnosis of S. mansoni compared with the ELISAs already described, 11, 12 their potential value in identifying S. haematobium infections is demonstrated in this study.
MATERIALS AND METHODS
Parasites and antigens. Schistosoma adult worms were collected by perfusion of the hepatic portal system of golden hamsters at seven weeks (S. mansoni) or at least 16 weeks (S. haematobium) after infection. Eggs were isolated from infected hamster liver (S. mansoni) or gut (S. haematobium) by means of homogenization and trypsinization. 13 Adult worm antigen (AWA), SEA, and the trichloroacetic acid (TCA)-soluble (7.5 % w/v) fraction of SEA (SEA-TCA) were prepared as previously described. 14 Schistosoma mansoni HF was prepared according to Amador Pérez and Wright 15 with some modifications. Briefly, 400,000 eggs were incubated in distilled water for 2 hr at 28ЊC under a light source. After removal of the eggs and miracidia by centrifugation and filtration, the hatching fluid was freezedried.
Monoclonal antibodies. For preparation of anti-egg MAbs, BALB/c mice were immunized with 100 g of HF and given booster immunizations after two weeks and then every fourth week with 50 g of HF antigen. The final booster immunization was given three days prior to the fusion. Spleen cells were fused with SP2/0 mouse myeloma cells three (fusion 290) or five (fusion 291) months postprimary immunization. Hybridoma cells were selected as described in the Results, and cloned by limiting dilutions. The MAbs were produced by induction of ascitic fluid in mice. Isotypes were determined in the HF-ELISA or the immunofluorescent assay using anti-mouse isotype-specific peroxidase or fluorescein isothiocyanate conjugates. The MAbs were purified as described. 16 The MAbs with isotype IgM were labeled with biotin-XX-hydrazide (Calbiochem, San Diego, CA) and the IgG MAbs were labeled with sulfosuccinimidyl-6-(biotinamido) hexanoate (Immunopure, NHS-LC-Biotin; Pierce, Rockford, IL), according to the manufacturer's instructions.
Hatching fluid ELISA. Flat-bottom, 96-well, polystyrene, microtitration plates (Maxisorp; Nunc, Roskilde, Denmark) were coated with S. mansoni HF antigen (5 g/ml) in 0.035 M phosphate-buffered saline (PBS), pH 7.8 and incubated for 1 hr at 37ЊC while shaking. After each incubation step, the plates were washed with 20-fold diluted PBS. Nonspecific binding sites were blocked with 0.25% bovine serum albumin (BSA; fraction V; Boehringer, Mannheim, Germany) in PBS. Subsequently, the wells were incubated with 70 l of hybridoma cell supernatant with 10 l of PBS containing 0.1% (w/v) BSA and 1.6% (v/v) Tween 20 (Sigma, St. Louis, MO). For detection of bound antibodies, peroxidase conjugates of anti-mouse immunoglobulin-or isotype-specific antibodies (Nordic, Tilburg, The Netherlands) were used. After color development using 3,3',5,5'-tetramethylbenzidine (TMB) as a substrate, the absorbance was measured at 630 nm.
Immunofluorescent assay (IFA). The IFA was carried out on sections of frozen liver or gut (artificially supplemented with adult worms obtained by perfusion) of hamsters infected with S. mansoni or S. haematobium. 17 Immunodiffusion (ID). Immunodiffusion was carried out as previously described. 11 Ascitic fluid or ammonium sulfate precipitate from hybridoma cell culture supernatant was used as the antibody and AWA or SEA (1.0 mg) was used as the antigen.
Sandwich ELISA. Microtitration plates were coated overnight at 4ЊC with MAb (5 g/ml of PBS). Plates were blocked with 0.1% BSA. Every incubation step was for 1 hr at 37ЊC unless indicated otherwise. The plates were first incubated with a dilution series of the antigens (AWA, SEA) or samples in assay buffer (PBS containing 0.1% BSA and 0.3% Tween 20) and then with an optimal dilution of the biotinylated MAb. Bound MAb was detected with streptavidin/alkaline phosphatase (Zymed, San Francisco, CA) after incubation for 25 min. After a final washing procedure, 3 mM 4-nitrophenyl phosphate diluted in 0.1 M diethanolamine containing 0.5 mM MgCl 2 , pH 9.6, was added. The absorbance was read at 405 nm after overnight incubation at 4ЊC. The reactivity with Schistosoma antigens was expressed as the lower detection limit (LDL in nanograms of SEA/ml or micrograms of AWA/ml). The reactivity of urine or serum samples was expressed as the reciprocal value of the last sample dilution showing color greater than background level (mean absorbance of 10 buffer controls plus three times the standard deviation).
For the pilot study, the same protocol was used, with 2% fetal calf serum added to the biotinylated 290-2E6-A MAb. The relative CSEA concentration of the samples was calculated from a standard curve of SEA-haematobium.
Competitive inhibition ELISA. Microtitration plates were coated with SEA (1 g/ml), and subsequently blocked with 0.1% BSA. Nonbiotinylated MAbs were serial diluted (starting at 50 g/ml) in assay buffer and a previously determined subsaturating level of biotinylated MAb (1 g/ml) was added. After incubation for 30 min at 37ЊC while shaking, the plates were washed and successively incubated with a streptavidin-peroxidase conjugate (Dakopatts, Glostrup, Denmark) and TMB solution. The inhibition of the binding of the biotinylated MAb by nonbiotinylated MAb was expressed as a percentage of the background-corrected absorbance of the wells without inhibitor.
Mild periodate oxidation. Periodate sensitivity of the epitopes was evaluated according to the method of Woodward and others. 18 Briefly, microtitration plates coated with SEA (1 g/ml) were treated with a concentration series of sodium metaperiodate (0-20 mM NaIO 4 in 50 mM sodium acetate, pH 4.5) in the dark. After blocking the aldehyde groups with 50 mM sodium borohydride in PBS, biotinylated MAb solutions were added. The plates were further processed as described for the competitive inhibition ELISA.
Screening with pools of patient sera and urine samples. For the screening of the diagnostic potential of the selected MAbs, pools of urine or serum samples of S. mansoni-infected individuals (from Senegal, Zaire, or Burundi) and pools from Dutch uninfected individuals (negative controls) were used. In addition, serum and urine samples of individuals (from Gabon or Cameroon) heavily infected with S. haematobium were tested. Serum samples were treated with TCA to remove interfering proteins and to dissociate immune complexes. 19 Whenever the results were positive or inconclusive, the test was repeated with single urine or serum samples. Reactivity of the S. mansoni-infected pools was confirmed by the previously established S. mansoni CSEA-specific ELISA using the 114-5B1-A and 114-4D12-A MAbs (both isotype IgG1) for coating and detection. 11 Study population. To determine the sensitivity of the most promising assays, a pilot study was conducted on a population from the Kilifi District in Kenya, an area endemic for S. haematobium, with no reported cases of S. mansoni. The study population was composed of school children (6-17 years of age). Before commencing the study, permission to participate was obtained from the pupils' parents, the education office, and the local administration. The study protocol was approved by the Kenya Ministry of Health Ethical Review Committee and the Danish Central Medical Ethics Committee. For ethical reasons, all children who were positive for S. haematobium were treated with praziquantel. Urine samples were collected between 10:00 AM and 2:00 
* The localization of fluorescence with sections of frozen livers from hamsters infected with Schistosoma mansoni (m) or S. haematobium (h) is summarized (ϩ ϭ positive; Ϯ ϭ marginal; Ϫ ϭ negative). Exs ϭ excretory system; P-M ϭ parenchyma and muscles; Teg ϭ tegument; Mir ϭ miracidia; Es ϭ excretory/secretory antigen; Gran ϭ granuloma; AWA ϭ adult worm antigen; SEA ϭ soluble egg antigen.
PM. Aliquots for determination of soluble egg antigens were taken and kept at Ϫ20ЊC until use. Urine filtration for the determination of eggs was performed following a standard procedure (Kahama AI, unpublished data). Egg counts exceeding 1,000 per filter were arbitrarily expressed as Ͼ 1,000 eggs per 10 ml of urine (ep10ml). The range was from 0 to Ͼ 1,000 ep10ml with a median of 85 ep10ml. All children had S. haematobium eggs in their urine and/or a positive hematuria or a urinary tract pathology detected by ultrasound.
To determine the specificity of the assays, a group consisting of 10 S. mansoni-infected patients from Burundi was included. 20 The fecal egg excretion ranged from 20 to 4,820 eggs per gram of feces (epg) (median ϭ 430 epg). Additionally, 14 negative control samples from healthy Dutch individuals, with no history of schistosomiasis, were tested.
RESULTS
Hybridoma supernatants were screened with an IFA on cryostate liver sections of S. mansoni-infected hamsters and with an HF-ELISA. Hybridoma supernatants positive in the HF-ELISA, and in the IFA showing a strong reactivity with eggs and antigens around eggs were selected for further studies, while those showing a strong fluorescence with gut-associated antigens were excluded. Hybridoma cells were cloned and ammonium sulfate precipitates of the supernatants were tested by ID to select for MAbs recognizing repetitive epitopes.
For selected hybridomas, MAbs were produced by induction of ascitic fluid in mice and again analyzed by IFA and ID for both S. mansoni and S. haematobium. The reactivity pattern as revealed by the IFA is summarized in Table 1 . Fluorescence was never restricted to the eggs alone because common epitopes were shared with tissue components of adult worms (e.g., excretory system, tegument, muscles, parenchyma) for each MAb. Most MAbs showed a very similar reactivity with both S. mansoni and S. haematobium adult worms and eggs. The MAbs 290-1E2-A and 290-3H4-A were negative with SEA by ID, whereas MAbs 290-2E5-A and 290-3H2-A also showed a precipitation line with AWA of both S. mansoni and S. haematobium. Therefore, these MAbs were excluded from further analysis. The precipitation line of MAb 290-2E6-A was very weak with both SEA preparations. The biotinylated MAb 291-2G3-A showed a very strong binding to the coated MAb 291-2G3-A in a sandwich ELISA and had to be excluded as well. Monoclonal antibody 291-2G3-A was an IgG3 isotype, while all other MAbs were IgM isotypes.
The diagnostic potential of the remaining MAbs was studied using homologous sandwich ELISAs and testing antigen preparations and urine pools ( Table 2 ). In addition to a sensitive detection of SEA-mansoni, all MAbs reacted with the TCA-soluble fraction of SEA-mansoni (SEA-TCA) (range ϭ 1-62 ng of SEA-TCA/ml. The MAbs of fusion 291 and MAb 290-2E6-A also showed a sensitive detection of SEAhaematobium ( Table 2 ).
All MAbs described in this study (except 290-2D9-A) showed reactivity with urine samples of individuals heavily infected with S. haematobium ( Table 2 ). The most promising MAbs for immunodiagnosis of S. haematobium infection were 290-2E6-A, 291-3D5-A, and 291-5D5-A since they showed no reactivity with S. mansoni urine pools or with negative control pools. For CSEA detection in urine samples of S. mansoni-infected individuals, none of the MAbs performed better than the previously described S. mansoni-specific MAbs 114-5B1-A and 114-4D12-A. In addition, pools of serum of S. mansoni-infected individuals and serum samples of S. haematobium-infected individuals were assayed (starting at a 1:16 dilution), but none of the MAbs showed a sensitive detection of CSEA.
A pilot study was conducted with three homologous sand- ‡ The four samples that tested negative were nonreactive in all three ELISAs.
wich ELISAs using MAbs 290-2E6-A, 291-3D5-A, or 291-5D5-A as capture and detection antibody: ELISA-2E6, ELI-SA-3D5, and ELISA-5D5, respectively. Untreated urine samples of 47 individuals from an area in Kenya endemic for S. haematobium, 14 negative controls, and 10 S. mansoni-infected individuals were included ( Table 3 ). The three ELISAs showed a comparable sensitive detection of CSEA in urines from S. haematobium-infected individuals with medians of 566, 416, and 519 ng of SEA-haematobium/ml for ELISA-2E6, ELISA-3D5, and ELISA-5D5, respectively (ranges ϭ 0-34, 0-12, and 0-24 g of SEA-haematobium/ ml, respectively). For urinary egg counts greater than 49 ep10ml, only ELI-SA-2E6 showed a 100% sensitivity, while for a lower positive egg count the sensitivity was 69% (Table 3 ). The four parasitologically positive samples that were negative using ELISA-2E6 were also negative with the other two ELISAs. The specificity was 92% for ELISA-2E6, while the (nonspecific) reactivity observed with the negative control sample and the S. mansoni sample was rather low. Moreover, of the 39 positive S. haematobium urines indicated in Table 3 , 37 urine samples showed an antigen level higher than the nonhaematobium samples.
The ELISA-3D5 showed an additional reactivity with three urine samples of S. mansoni-infected individuals. This reactivity was high for two of the three samples, indicating that ELISA-3D5 lacks specificity for S. haematobium. While the reactivity of the 14 control samples was well below the background of ELISA-5D5, an extensive cross-reactivity with urine samples from eight out 10 S. mansoni-infected individuals was observed (Table 3) . However, the CSEA levels (or titers) could not be determined because the curves of the dilution series of the samples were not parallel to the standard curve of either SEA-haematobium or SEA-mansoni.
A significant correlation was found between the urinary egg-output of patients infected with S. haematobium and the level of CSEA for each assay. The highest correlation coefficient with egg-output was found with ELISA-2E6 (Spearman rho ϭ 0.60, P Ͻ 0.001; n ϭ 47), followed by ELISA-5D5 (rho ϭ 0.47, P Ͻ 0.001), and ELISA-3D5 (rho ϭ 0.38, P Ͻ 0.01). The assay results showed a good correlation (Spearman rho Ͼ 0.74, P Ͻ 0.001), with the highest correlation coefficient for ELISA-2E6 and ELISA-3D5 (rho ϭ 0.82) and the lowest for ELISA-3D5 and ELISA-5D5.
In the IFA, MAbs 290-2E6-A and 291-3D5-A both showed a similar reactivity pattern with adult worms of S. mansoni and S. haematobium (Table 1 and Figure 1 ). The reactivity of MAb 291-5D5-A was different from the former two. The MAbs showed a similar reactivity with eggs. Figure 1 shows the reactivity of MAb 290-2E6-A with eggs. While some eggs were completely nonreactive, others showed fluorescence between miracidia and eggshell and outside the egg, suggesting that MAb 290-2E6-A displays a differential reactivity with dead and living eggs. * Values are the concentration of unlabeled MAb (g/ml) at which the binding of biotin conjugate (1 g/ml) to Schistosoma haematobium soluble egg antigen-coated plates was inhibited 50%. -ϭ no inhibition noticed with the MAb concentrations used. * Soluble egg antigen (SEA)-coated plates were treated with a concentration series of NalO 4 (0-20 mM) and reduction of MAb binding was calculated. The concentration of NalO 4 (mM) is indicated at which the MAb showed a 50% decrease in binding to the coated antigen.
It is conceivable that all three MAbs detect the same antigen(s) of SEA-haematobium. Indeed, in a heterologous sandwich ELISA format, using one MAb for capturing and another as a conjugate, all six possible combinations showed a sensitive detection of SEA-haematobium. The LDL ranged from 16-156 ng of SEA-haematobium/ml, with the most unsensitive LDL observed for MAb 291-5D5-A coating combined with biotinylated MAb 291-3D5-A. These data clearly show that all three MAbs detect epitopes that are present on the same antigen(s).
In a competitive ELISA, MAbs 290-2E6-A and 291-3D5-A showed a mutual competition in binding the epitopes on S. haematobium egg antigens ( Table 4 Periodate treatment of coated SEA reduced the binding of all MAbs studied (Table 5) . Binding of MAb 291-5D5-A was markedly less affected by periodate treatment than MAbs 290-2E6-A and 291-3D5-A, which were equally sensitive, again indicating that MAb 291-5D5-A recognizes a clearly different epitope. DISCUSSION Recently, we described two MAbs specific for S. mansoni CSEA. 11, 12 Although we were able to specifically detect CSEA in serum and urine samples of S. mansoni-infected individuals, these assays lacked sensitivity for light infections as determined by egg output in feces. In an attempt to develop a more sensitive assay, the present study was undertaken to elicit a different set of MAbs reactive with S. mansoni-derived egg antigens.
To this end, mice were immunized with S. mansoni HF containing miracidial excretory or surface coat products and two fusions were carried out. The initial selection of relevant hybridomas was based on the reactivity with S. mansoni eggs in IFA and the recognition of multiple epitopes on S. mansoni SEA as revealed by ID. However, none of these MAbs showed species specificity, but they also reacted strongly with S. haematobium adult worms, eggs, and SEA. This finding is consistent with many other studies demonstrating the presence of epitopes shared by S. mansoni and S. haematobium. 21, 22 All MAbs when tested in a homologous sandwich ELISA showed a sensitive detection of the TCA-soluble fraction of SEA-mansoni. Together with the precipitation of antigens by ID, this suggests that the recognized repeating epitopes are of a carbohydrate nature. This is further supported for five of the MAbs (290-2E6-A, 291-3D5-A, 291-3E9-A, 291-5D5-A, and 291-3A4-A) by their sensitivity to mild periodate oxidation. It is presently unknown whether the reactive epitopes are present on polysaccharide, glycoprotein, or glycolipid antigens.
The MAbs were tested as potential immunodiagnostic reagents in a homologous sandwich ELISA format to detect CSEA in sera and urine samples of S. mansoni-or S. haematobium-infected individuals. When testing samples of S. mansoni-infected individuals, all MAbs performed significantly worse than the previously described S. mansoni-specific 114-5B1-A and 114-4D12-A MAbs. However, in contrast to the latter two MAbs, 11 MAbs from the present study detected CSEA in pooled urine samples of S. haematobiuminfected individuals. None of these MAbs was able to detect CSEA in TCA-treated serum of S. mansoni-or S. haematobium-infected individuals, whereas SEA artificially added to serum samples could still be demonstrated after TCA treatment. Most likely, levels of tissue egg-derived antigen in the circulation are too low to be detected at the dilutions tested. Alternatively, a considerable amount of the CSEA detected in urine samples of S. haematobium-infected individuals might be released by eggs in the urine. As such, in the case of S. mansoni, urines would (indeed) be negative.
The performance of ELISA-2E6, ELISA-3D5, and ELI-SA-5D5 was studied in more detail by assaying urine samples of Kenyan children from an area endemic for S. haematobium. All three assays showed a sensitive detection of egg antigen and a significant positive correlation with urinary eggs. Taking into account the low (cross)-reactivity with control urines and with S. mansoni-infected urines, ELISA-2E6 is the most promising of the three ELISAs tested. For urinary egg counts greater than 49 ep10ml, the assay showed 100% sensitivity, while for a lower positive egg count the sensitivity was 69% (overall sensitivity ϭ 90%). The specificity was 92% under standard assay conditions. Further studies to increase the sensitivity and specificity by optimization of the assay (including sample pretreatment) are currently underway.
The MAbs 290-2E6-A and 291-3D5-A showed a reactivity pattern that was similar for adult worms of S. mansoni and S. haematobium as revealed by the IFA. Their mutual competition in binding to coated S. haematobium egg antigens indicates that closely related epitopes are recognized. Moreover, the epitopes displayed a similar susceptibility to periodate treatment. These epitopes are clearly different from, and not in a close proximity to, the epitopes recognized by MAb 291-5D5-A as shown by IFA, competition ELISA, and periodate treatment. Using heterologous sandwich ELISAs, it could be demonstrated that antigens are present carrying epitopes for every combination of these three MAbs. It is not clear whether the same antigen(s) is recognized.
In this study, we sought MAbs recognizing repeating epitopes on egg-antigens by taking a positive ID in the selection. The presence of repeating epitopes allows for using only one MAb as both capture and detection antibody in a sandwich immunoassay. Alternatively, a combination of two MAbs, a concept already used for detection of CCA 16 and S. mansoni CSEA 12 , may result in enhanced sensitivity. Initial analysis of several combinations of MAbs used in this study, however, showed that no increase in sensitivity could be achieved.
At present, hematuria, proteinuria, and dysuria are considered useful indicators for the presence of a chronic S. haematobium infection. A reagent stick method to determine hematuria has been shown to be a simple and sensitive technique, suitable for mass screening, but it lacks specificity. 23 Recent studies indicated eosinophil cationic protein in urine as a potential marker for S. haematobium-induced morbidity. 24 However, these techniques are associated with the pathology of the disease and are not specific indicators of an active S. haematobium infection. Specific detection of urinary egg antigens is expected to mark an (active) infection with S. haematobium. Recently, Bosompem and others 10 described a field-applicable dipstick assay for diagnosis of urinary schistosomiasis using a S. haematobium-specific MAb detecting a 29-kD protein antigen in SEA, and reported a sensitivity of 100%. However, egg count levels were not mentioned, which complicated a fair comparison with our study, since assay-sensitivity is usually dependent on intensity of infection.
This study shows that the newly developed ELISA-2E6 is a promising tool for the sensitive and specific diagnosis of infection with S. haematobium. In addition, the assay showed a highly significant correlation with egg-output. Further studies will be concerned with the application of ELI-SA-2E6 in epidemiologic studies and with the evaluation of its applicability to the follow-up of chemotherapy.
